3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Terminated
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Neoplasm Metastasis
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Neuroepithelial
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Epstein-Barr Virus Infections
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Radiosurgery
12
Temozolomide
10
Radiotherapy
10
Magnetic Resonance Spectroscopy
7
Erlotinib Hydrochloride
6
Bevacizumab
6
Surgical Procedures, Operative
5
Pemetrexed
5
Gefitinib
5
Drug Therapy
5
Carboplatin
5
pyrotinib
4
icotinib
4
aumolertinib
4
Trastuzumab
3
Spermine Synthase
3
Radiation
3
Lomustine
3
Etoposide
3
Dexmedetomidine
3
Chlorotoxin
3
Carmustine
3
osimertinib
2
camrelizumab
2
apatinib
2
Tyrosine Kinase Inhibitors
2
Thiotepa
2
Surveys and Questionnaires
2
Sevoflurane
2
Propofol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Brain Neoplasms
×
Valproic Acid
×
Clear all
NCT03243461
2022-06-06
HIT-HGG-2013
University of Göttingen
Phase 3
Unknown
167 enrolled